Universal Vision Biotechnology Co Ltd
Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy services, as well as provides medical and scientific prescription eyeglasses. Furt… Read more
Universal Vision Biotechnology Co Ltd (3218) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.083x
Based on the latest financial reports, Universal Vision Biotechnology Co Ltd (3218) has a cash flow conversion efficiency ratio of 0.083x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$319.86 Million) by net assets (NT$3.87 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Universal Vision Biotechnology Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how Universal Vision Biotechnology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Universal Vision Biotechnology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Universal Vision Biotechnology Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
KT Submarine Co. Ltd
KQ:060370
|
0.022x |
|
Lever Global Corporation
OTCQB:LVER
|
-1.470x |
|
LOG Commercial Properties e Participações S.A
SA:LOGG3
|
-0.017x |
|
Polyrocks Chemical Co Ltd
SHG:688669
|
0.030x |
|
AB Fagerhult
F:2F0
|
0.023x |
|
Bank of Ayudhya PCL
BK:BAY
|
0.097x |
|
Bharat Bijlee Limited
NSE:BBL
|
-0.017x |
|
UE Furniture Co Ltd
SHG:603600
|
0.098x |
Annual Cash Flow Conversion Efficiency for Universal Vision Biotechnology Co Ltd (2003–2024)
The table below shows the annual cash flow conversion efficiency of Universal Vision Biotechnology Co Ltd from 2003 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$3.76 Billion | NT$1.67 Billion | 0.445x | -4.20% |
| 2023-12-31 | NT$3.34 Billion | NT$1.55 Billion | 0.465x | +3.68% |
| 2022-12-31 | NT$2.83 Billion | NT$1.27 Billion | 0.448x | +14.47% |
| 2021-12-31 | NT$2.33 Billion | NT$911.77 Million | 0.392x | -3.44% |
| 2020-12-31 | NT$2.04 Billion | NT$827.08 Million | 0.406x | +64.02% |
| 2019-12-31 | NT$1.70 Billion | NT$419.18 Million | 0.247x | +45.68% |
| 2018-12-31 | NT$1.61 Billion | NT$273.07 Million | 0.170x | +13.59% |
| 2017-12-31 | NT$1.58 Billion | NT$236.48 Million | 0.149x | -32.07% |
| 2016-12-31 | NT$1.16 Billion | NT$255.13 Million | 0.220x | +37.79% |
| 2015-12-31 | NT$1.15 Billion | NT$183.54 Million | 0.160x | -17.91% |
| 2014-12-31 | NT$1.14 Billion | NT$221.81 Million | 0.194x | +16.31% |
| 2013-12-31 | NT$1.10 Billion | NT$183.66 Million | 0.167x | +144.36% |
| 2011-12-31 | NT$1.14 Billion | NT$77.91 Million | 0.068x | -46.06% |
| 2010-12-31 | NT$663.76 Million | NT$84.19 Million | 0.127x | -26.41% |
| 2008-12-31 | NT$539.22 Million | NT$92.94 Million | 0.172x | -0.41% |
| 2006-12-31 | NT$546.91 Million | NT$94.66 Million | 0.173x | -57.01% |
| 2004-12-31 | NT$305.87 Million | NT$123.14 Million | 0.403x | +71.74% |
| 2003-12-31 | NT$235.39 Million | NT$55.18 Million | 0.234x | -- |